Vise Technologies Inc. bought a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 21,698 shares of the financial services provider’s stock, valued at approximately $1,745,000.
A number of other large investors also recently modified their holdings of MET. Diamond Hill Capital Management Inc. bought a new stake in MetLife during the 1st quarter worth $336,965,000. Nuveen LLC bought a new position in MetLife in the first quarter valued at about $312,946,000. Price T Rowe Associates Inc. MD boosted its stake in shares of MetLife by 7.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider’s stock valued at $2,126,734,000 after purchasing an additional 1,824,907 shares in the last quarter. Alyeska Investment Group L.P. bought a new stake in shares of MetLife during the first quarter worth about $68,030,000. Finally, AQR Capital Management LLC increased its stake in shares of MetLife by 85.0% in the first quarter. AQR Capital Management LLC now owns 1,321,881 shares of the financial services provider’s stock valued at $104,270,000 after buying an additional 607,333 shares during the period. 94.99% of the stock is currently owned by institutional investors.
MetLife Stock Up 0.7%
Shares of MetLife stock opened at $77.74 on Wednesday. The stock’s 50-day moving average is $79.90 and its 200 day moving average is $78.89. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05. The firm has a market cap of $51.70 billion, a price-to-earnings ratio of 13.18, a PEG ratio of 0.70 and a beta of 0.87. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16.
MetLife Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be given a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Tuesday, November 4th. MetLife’s payout ratio is presently 42.75%.
Wall Street Analysts Forecast Growth
Several research firms recently commented on MET. Jefferies Financial Group lifted their target price on shares of MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a research report on Monday, August 11th. Piper Sandler downgraded shares of MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price target for the company. in a research note on Friday, September 19th. Cowen reissued a “buy” rating on shares of MetLife in a research note on Friday, August 22nd. Wolfe Research upgraded MetLife to a “strong-buy” rating in a report on Tuesday, September 16th. Finally, Keefe, Bruyette & Woods cut their target price on MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a report on Tuesday. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, MetLife currently has an average rating of “Moderate Buy” and a consensus target price of $95.00.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Investing In Preferred Stock vs. Common Stock
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Amazon Is One of the Clearest Buys If the Market Dips Again
- How to Buy Cheap Stocks Step by Step
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
